These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
351 related items for PubMed ID: 19557981
21. Successful fibrinolytic treatment of prosthetic heart valve thrombosis using streptokinase. Sakr SA, Abdel-Shakour H, Ramadan MM. Acta Clin Belg; 2015 Jun; 70(3):159-66. PubMed ID: 25495280 [Abstract] [Full Text] [Related]
25. Successful thrombolysis of late, non-obstructive mitral bioprosthetic valve thrombosis: case report and review of the literature. Pozsonyi Z, Lengyel M. J Heart Valve Dis; 2011 Sep; 20(5):526-30. PubMed ID: 22066356 [Abstract] [Full Text] [Related]
26. Assessment of Anti-Tissue Type Plasminogen Activator Antibodies in Patients With Prosthetic Heart Valve Thrombosis: The ATA Trial. Özkan M, Kalçık M, Gürsoy MO, Öcal L, Griffini S, Karakoyun S, Yesin M, Gündüz S, Astarcıoğlu MA, Bayam E, Cerşit S, Aykan AÇ, Cugno M. J Cardiovasc Pharmacol Ther; 2016 Jul; 21(4):372-80. PubMed ID: 26657322 [Abstract] [Full Text] [Related]
27. Safety of thrombolytic therapy in patients with prosthetic heart valve thrombosis who have high international normalized ratio levels. Farzaneh K, Mortazavi SH, Oraii A, Abbasi K, Salehi Omran A, Ahmadi Tafti SH, Bozorgi A, Kazemi Saeed A, Salarifar M, Sadeghian S. J Card Surg; 2020 Oct; 35(10):2522-2528. PubMed ID: 33043663 [Abstract] [Full Text] [Related]
28. Thrombolysis as first choice therapy in prosthetic heart valve thrombosis. A study of 68 patients. Cáceres-Lóriga FM, Pérez-López H, Morlans-Hernández K, Facundo-Sánchez H, Santos-Gracia J, Valiente-Mustelier J, Rodiles-Aldana F, Marrero-Mirayaga MA, Betancourt BY, López-Saura P. J Thromb Thrombolysis; 2006 Apr; 21(2):185-90. PubMed ID: 16622616 [Abstract] [Full Text] [Related]
30. Thrombolysis of an acute prosthetic mitral valve thrombosis presented with cardiogenic shock under the guidance of continuous transoesophageal monitoring. Biteker M, Duran NE, Gündüz S, Gökdeniz T, Kaya H, Aykan AC, Ozkan M. Eur J Echocardiogr; 2009 May; 10(3):468-70. PubMed ID: 19252185 [Abstract] [Full Text] [Related]
33. Clinical outcomes of patients with mitral prosthetic valve obstructive thrombosis treated with streptokinase or tenecteplase. Kiran GR, Chandrasekhar P, Mohammad Ali S. Indian Heart J; 2021 May; 73(3):365-368. PubMed ID: 34154758 [Abstract] [Full Text] [Related]
34. Paraprosthetic leak unmasked by thrombolysis for thrombosed mitral valve. Yusuf MM, Archbold RA, Wood A, Dymond D. Heart; 2004 Apr; 90(4):e18. PubMed ID: 15020536 [Abstract] [Full Text] [Related]
35. Improvement of endothelial function early after thrombolytic therapy in patients with prosthetic heart valve thrombosis. Çakal B, Kalçık M, Güner A, Yesin M, Gürsoy MO, Gündüz S, Karakoyun S, Bayam E, Kalkan S, Özkan M. Turk Kardiyol Dern Ars; 2020 Sep; 48(6):566-575. PubMed ID: 32955025 [Abstract] [Full Text] [Related]
36. Prolonged Infusions of Low-Dose Thrombolytics in Elderly Patients With Prosthetic Heart Valve Thrombosis. Gündüz S, Özkan M, Yesin M, Kalçık M, Gürsoy MO, Karakoyun S, Astarcıoğlu MA, Aykan AÇ, Gökdeniz T, Biteker M, Duran NE, Yıldız M. Clin Appl Thromb Hemost; 2017 Apr; 23(3):241-247. PubMed ID: 26447199 [Abstract] [Full Text] [Related]